Atossa Therapeutics (ATOS) Other Working Capital Changes (2023 - 2026)

Atossa Therapeutics (ATOS) has reported Other Working Capital Changes for 4 consecutive years, with -$34000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Working Capital Changes rose 90.66% year-over-year to -$34000.0 in Q2 2026; TTM through Jun 2026 was $718000.0, a 715.91% increase from a year earlier, with the FY2025 full-year figure at -$37000.0, up 96.29% from the prior year.
• Other Working Capital Changes was -$34000.0 for Q2 2026 at Atossa Therapeutics, down from $699000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $2.2 million in Q4 2022 and troughed at -$1.6 million in Q1 2023.
• A 5-year average of $92121.6 and a median of $12995.0 in 2019 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes slumped 3582.35% in 2024 and soared 155.11% in 2026, its largest moves.
• Over 4 years, Other Working Capital Changes stood at -$462000.0 in 2023, then soared by 146.54% to $215000.0 in 2024, then jumped by 154.88% to $548000.0 in 2025, then tumbled by 106.2% to -$34000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$34000.0 (Q2 2026), $699000.0 (Q1 2026), and $548000.0 (Q4 2025), per Business Quant data.